These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29200200)

  • 1. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
    Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
    Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
    Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
    Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
    Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
    Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
    Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
    Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
    Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
    Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
    Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death.
    Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM
    Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway.
    Badawy AM; El-Naga RN; Gad AM; Tadros MG; Fawzy HM
    Chem Biol Interact; 2019 Aug; 308():137-146. PubMed ID: 31103702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
    Yu X; Meng X; Xu M; Zhang X; Zhang Y; Ding G; Huang S; Zhang A; Jia Z
    EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.
    Nojiri T; Hosoda H; Kimura T; Miura K; Ishikane S; Tokudome T; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):123-9. PubMed ID: 25385303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis.
    Wang F; Wang JN; He XY; Suo XG; Li C; Ni WJ; Cai YT; He Y; Fang XY; Dong YH; Xing T; Yang YR; Zhang F; Zhong X; Zang HM; Liu MM; Li J; Meng XM; Jin J
    Acta Pharmacol Sin; 2022 Feb; 43(2):330-341. PubMed ID: 33833407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.
    He XY; Wang F; Suo XG; Gu MZ; Wang JN; Xu CH; Dong YH; He Y; Zhang Y; Ji ML; Chen Y; Zhang MM; Fan YG; Wen JG; Jin J; Wang J; Li J; Zhuang CL; Liu MM; Meng XM
    Br J Pharmacol; 2023 Oct; 180(20):2641-2660. PubMed ID: 37248964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI).
    Ozkok A; Ravichandran K; Wang Q; Ljubanovic D; Edelstein CL
    Toxicol Lett; 2016 Jan; 240(1):105-13. PubMed ID: 26546572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation.
    Hui D; Rui-Zhi T; Jian-Chun L; Xia Z; Dan W; Jun-Ming F; Li W
    J Ethnopharmacol; 2020 Apr; 252():112637. PubMed ID: 32004631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
    Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
    Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis.
    Tian R; Tang S; Zhao J; Hao Y; Zhao L; Han X; Wang X; Zhang L; Li R; Zhou X
    Ren Fail; 2024 Dec; 46(1):2354918. PubMed ID: 38757723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
    Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
    PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Role for Tubular Necroptosis in Cisplatin-Induced AKI.
    Xu Y; Ma H; Shao J; Wu J; Zhou L; Zhang Z; Wang Y; Huang Z; Ren J; Liu S; Chen X; Han J
    J Am Soc Nephrol; 2015 Nov; 26(11):2647-58. PubMed ID: 25788533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.